Jürgen Kreis

Part of Deutsche Effecten & Wechsel Beteiligungs AG, Deutsche Effecten & Wechsel Beteil AG (Asset Mgmt) specializes in private equity fund. The company is based in Jena, Germany.

DEWB AG (Venture Capital) (DEWB-VC) is the venture capital subsidiary of Deutsche Effecten & Wechsel Beteiligungs AG (FR: EFF), headquartered in Jena, Germany. The firm, established in 1997, provides equity capital, corporate development expertise and network support to strong growth, medium-sized technology companies.

NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.

SMARTRAC TECHNOLOGY Dresden GmbH engages in the design, manufacture, and testing of electronic and electromechanical components, particularly miniaturized components. It specializes in technologies for the production of electronic circuit boards, installation of microassemblies, as well as the development and manufacture of equipment for the production and testing of microasseblies. The company was founded in November 1994 and is headquartered in Dresden, Germany.

Nanotron Technologies GmbH develops and provides wireless communications systems. The firm’s platform consists of chips, modules, and software that enable real-time positioning and concurrent wireless communication. Its products include swarm, nano location systems (RTLS), and transceiver. The company was founded by Manfred Koslar and Zbigniew Ianelli in 1991 and is headquartered in Berlin, Germany.

Part of Deutsche Effecten & Wechsel Beteiligungs AG, DEWB Effecten GmbH operates as an investment holding German company. The company is based in Jena, Germany. The CEO of the company is Bertram Köhler.